Insider · CIK 0001837741
Michael Mano
Files at KPTI (Karyopharm Therapeutics Inc.). First filing Mar 6, 2025, latest Mar 3, 2026.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
KPTI: Karyopharm Therapeutics Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 36Weak | Karyopharm Therapeutics Inc. | $33k 3,526 shares | -4% | +171% from low-5% from high | |
| 30Weak | Karyopharm Therapeutics Inc. | $1,505 234 shares | -1% | +77% from low-58% from high | |
| 35Weak | Karyopharm Therapeutics Inc. | $18k 2,793 shares | -12% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 2, 2026 | KPTI Karyopharm Therapeutics Inc. | SOpen-market sale Common Stock | -3,526 | $9.41 | $33k | 93,964 | Mar 3, 2026 |
| Jan 31, 2026 | KPTI Karyopharm Therapeutics Inc. | AGrant or award Common Stock | +32,415 | $0.00 | $0 | 97,490 | Feb 3, 2026 |
| Oct 15, 2025 | KPTI Karyopharm Therapeutics Inc. | AGrant or award Common Stock | +43,650 | $0.00 | $0 | 65,075 | Oct 16, 2025 |
| Sep 12, 2025 | KPTI Karyopharm Therapeutics Inc. | AGrant or award Common Stock | +612 | $0.00 | $0 | 21,659 | Sep 16, 2025 |
| Sep 15, 2025 | KPTI Karyopharm Therapeutics Inc. | SOpen-market sale Common Stock | -234 | $6.43 | $1,505 | 21,425 | Sep 16, 2025 |
| Mar 4, 2025 | KPTI Karyopharm Therapeutics Inc. | SOpen-market sale Common Stock | -2,793 | $6.29 | $18k | 21,047 | Mar 6, 2025 |
| Feb 28, 2025 | KPTI Karyopharm Therapeutics Inc. | AGrant or award Common Stock | +3,333 | $0.00 | $0 | 21,590 | Mar 4, 2025 |
| Feb 28, 2025 | KPTI Karyopharm Therapeutics Inc. | AGrant or award Common Stock | +2,250 | $0.00 | $0 | 23,840 | Mar 4, 2025 |
| Feb 28, 2025 | KPTI Karyopharm Therapeutics Inc. | AGrant or award Stock Option (right to buy)derivative | +6,666 | $0.00 | $0 | 6,666 | Mar 4, 2025 |
| Feb 28, 2025 | KPTI Karyopharm Therapeutics Inc. | AGrant or award Stock Option (right to buy)derivative | +4,500 | $0.00 | $0 | 4,500 | Mar 4, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.